DI VITO, CLARA
DI VITO, CLARA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Disrupted innate lymphoid cell development shapes prognosis and therapy outcomes in myelodysplastic syndrome patients
2025 L. Orlandi, M. Calvi, A. Frigo, E. Riva, G. Maggioni, A. Russo, E. Saba, M. Ubezio, M. Giovanni Della Porta, C. Di Vito, D. Mavilio
Deciphering the role of immune system dysfunction in patients with Myelodysplastic Syndrome to refine the prognostic assessment and predict treatment response
2025 C. Di Vito, M. Calvi, E. Riva, M. Zampini, L. Dall’Olio, A. Merlotti, M. Ubezio, A. Russo, G. Maggioni, A. Frigo, L. Orlandi, E. Saba, D. Remondini, G. Castellani, G. Della Porta Matteo, D. Mavilio
A 40 colors spectral panel to decipher human NK cell involvement in the establishment of NeuroCOVID-19
2025 A. Frigo, C. DI VITO, F. Calcaterra, F. Masserini, A. Carletti, A. Nicotra, E. Perdixi, C. Gallo, P. Emiliano Doneddu, A. Forgione, S. Pomati, F. Terenghi, E. Nobile-Orazio, A. Riva, L. Pantoni, D. Mavilio
Multi-layered deep immune profiling, SARS-CoV-2 RNAemia and inflammation in unvaccinated COVID-19 individuals with persistent symptoms
2025 R. Rovito, V. Bono, N. Coianiz, V. Cazzetta, S. Franzese, J. Mikulak, C. Di Vito, F. Bai, G. Beaudoin-Bussières, A. Tauzin, M. Augello, C. Tincati, A. Santoro, E. Borghi, S. Marozin, A. Finzi, S. della Bella, D. Mavilio, G. Marchetti
Operationalisation of post-COVID condition case definition in a comprehensive research protocol
2025 F. Masserini, A. Nicotra, A. Forgione, F. Calcaterra, E. Perdixi, C. Di Vito, A. Carletti, C. Gallo, P.E. Doneddu, F. Terenghi, S. Pomati, E. Nobile-Orazio, A. Riva, D. Mavilio, L. Pantoni
Landscape of Immune Cell States and Ecosystems in Patients with Myelodysplastic Syndrome to Rene Prognostic Assessment and Predict Treatment Response
2024 E. Riva, M. Calvi, M. Zampini, L. Dall'Olio, A. Merlotti, A. Russo, G. Maggioni, L. Orlandi, A. Frigo, F. Ficara, L. Crisafulli, E. Sauta, S. D'Amico, E. Lugli, A. Campagna, M. Ubezio, C. Astrid Tentori, G. Todisco, L. Lanino, A. Buizza, D. Ventura, N. Pinocchio, E. Saba, A. Santoro, V. Santini, A.A. van de Loosdrecht, R.S. Komrokji, G. Garcia-Manero, P. Fenaux, L. Ades, U. Platzbecker, T. Haferlach, A. Medina Almeida, A.M. Zeidan, S. Kordasti, D. Remondini, G. Castellani, C. DI VITO, D. Mavilio, A. Matteo Giovanni Della Porta
Expansion of memory Vδ2 T cells following SARS-CoV-2 vaccination revealed by temporal single-cell transcriptomics
2024 S. Terzoli, P. Marzano, V. Cazzetta, R. Piazza, I. Sandrock, S. Ravens, L. Tan, I. Prinz, S. Balin, M. Calvi, A. Carletti, A. Cancellara, N. Coianiz, S. Franzese, A. Frigo, A. Voza, F. Calcaterra, C. DI VITO, S.A.M. DELLA BELLA, J. Mikulak, D. Mavilio
Multi-methodologic dissection of human Natural Killer cell ontogenesis to study the contribution of unconventional NK cell subsets and other Innate Lymphoid Cells (ILCs)
2024 A. Frigo, P. Marzano, M. Calvi, L. Orlandi, S. Terzoli, C. Favazzi, K. Chiappetta, G. Grappiolo, M. Loppini, C. DI VITO, D. Mavilio
Unveiling the roles of unconventional subsets and other Innate Lymphoid Cells in Natural Killer cell ontogenesis: the development of an autologous Bone Marrow niche mimicking system
2024 A. Frigo, S. Terzoli, M. Calvi, N. Coianiz, M. Loppini, C. DI VITO, D. Mavilio
DECIPHERING THE ROLE OF IMMUNE SYSTEM DYSFUNCTION IN MYELODYSPLASTIC SYNDROMES CLASSIFICATION AND PROGNOSIS
2024 E. Riva, M. Calvi, M. Zampini, L. Dall’Olio, A. Merlotti, A. Russo, G. Maggioni, A. Frigo, E. Saba, E. Lugli, D. Remondini, G. Castellani, C. DI VITO, D. Mavilio, M.G.D. Porta.
Persistence of KIRneg NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivation
2023 C. Di Vito, N. Coianiz, M. Calvi, S. Terzoli, E. Zaghi, S. Puccio, A. Frigo, J. Mariotti, C. De Philippis, D. Mannina, B. Sarina, R. Mineri, V.T.K. Le-Trilling, M. Trilling, L. Castagna, S. Bramanti, A. Santoro, D. Mavilio
Transcriptomic profile of TNF high MAIT cells is linked to B cell response following SARS-CoV-2 vaccination
2023 P. Marzano, S. Balin, S. Terzoli, S. Della Bella, V. Cazzetta, R. Piazza, I. Sandrock, S. Ravens, L. Tan, I. Prinz, F. Calcaterra, C. Di Vito, A. Cancellara, M. Calvi, A. Carletti, S. Franzese, A. Frigo, A. Darwish, A. Voza, J. Mikulak, D. Mavilio
What do we mean by long COVID? A scoping review of the cognitive sequelae of SARS-CoV-2 infection
2023 A. Nicotra, F. Masserini, F. Calcaterra, C. Di Vito, P.E. Doneddu, S. Pomati, E. Nobile-Orazio, A. Riva, D. Mavilio, L. Pantoni
Expansion of memory Vδ2 T cells following repeated BNT162b2 mRNA-based vaccine revealed by temporal single-cell transcriptomics
2023 S. Terzoli, P. Marzano, V. Cazzetta, R. Piazza, I. Sandrock, S. Ravens, L. Tan, I. Prinz, S. Balin, M. Calvi, A. Carletti, A. Cancellara, N. Coianiz, S. Franzese, A. Frigo, A. Voza, F. Calcaterra, C. DI VITO, S.A.M. DELLA BELLA, J. Mikulak, D. Mavilio
Expansion of memory Vδ2 T cells following repeated BNT162b2 mRNA-based vaccine revealed by temporal single-cell transcriptomics
2023 P. Marzano, S. Terzoli, V. Cazzetta, R. Piazza, I. Sandrock, S. Ravens, L. Tan, I. Prinz, S. Balin, M. Calvi, A. Carletti, A. Cancellara, N. Coianiz, S. Franzese, A. Frigo, A. Voza, F. Calcaterra, C. Di Vito, S.A.M. Della Bella, J. Mikulak, D. Mavilio
Relevance and heterogeneity of adaptive NK cells in the scenario of SARS-CoV-2: between vaccination and natural infection
2023 A. Frigo, S. Terzoli, M. Calvi, N. Coianiz, F. Calcaterra, C. DI VITO, D. Mavilio
The immunome profile of myelodysplastic syndrome patients defines different prognostic groups and shows a predictive potential to hypomethylating therapy
2023 M. Calvi, E. Riva, M. Zampini, L. Dall’Olio, A. Merlotti, A. Russo, G. Maggioni, A. Frigo, E. Saba, D. Remondini, G. Castellani, C. DI VITO, M. Giovanni Della Porta, D. Mavilio
Unveiling the roles of unconventional subsets and other Innate Lymphoid Cells in human Natural Killer cell ontogenesis
2023 A. Frigo, S. Terzoli, M. Calvi, P. Marzano, C. Favazzi, G. Grappiolo, M. Loppini, C. Di Vito, D. Mavilio
The expansion of adaptive-like NK cells following BNT162b2 vaccination contributes to the vaccine-induced protection against SARS-CoV-2 infection
2022 N. Coianiz, A. Frigo, S. Terzoli, D. Ramazzotti, R. Piazza, F. Calcaterra, C. DI VITO, D. Mavilio
Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications
2022 C. Di Vito, F. Calcaterra, N. Coianiz, S. Terzoli, A. Voza, J. Mikulak, S. Della Bella, D. Mavilio